查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
毛细管电泳市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按组件、模式、应用、终端用户、公司和地区划分
市场调查报告书
商品编码
1289642

毛细管电泳市场 - 2017-2027年全球行业规模、份额、趋势、机会和预测，按组件、模式、应用、终端用户、公司和地区划分

Capillary Electrophoresis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Mode, By Application, By End User, By Company and By Region
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球毛细管电泳市场预计将在2023-2027年预测期内出现令人瞩目的增长。主要因素包括各种类型的癌症、遗传性疾病和传染病的发病率不断增加，对创新疗法和药物的需求不断增加，以及研发投资的增加，这些都推动了市场的增长。毛细管电泳是一种分离方法，通过施加适当的电压，根据离子的电泳流动性进行分析分离。它之所以被广泛使用，是因为其结果更快，分离的分辨率高。这种电泳技术被广泛用于生物科学和临床研究。支持市场增长的其他因素有：研发活动的增加、蛋白质组学和基因组学研究的增加、个性化医疗需求的增加、老龄化人口的增加、医疗保健支出的增加、电泳在药物发现领域的应用增加、合并和战略收购的数量增加、对DNA分析的需求增加以及技术进步。

癌症发病率的上升

患有不同类型癌症的人越来越多，如乳腺癌、宫颈癌、肺癌和其他癌症，这促进了市场的增长。根据美国心脏协会的数据，心血管疾病每年导致1730万人死亡。由于癌症发病率的上升，对早期诊断和有效治疗的需求也在上升，这推动了市场的增长。例如，在2018年，根据国际癌症研究机构（IARC）的数据，全世界有1700万新的癌症病例和950万癌症死亡病例。

对个性化医疗的需求不断增加

如今，对精准医疗的需求正在上升，这是促进市场增长的一个关键因素。这要归功于它有可能以最佳反应定制治疗，并减少任何不良事件。它基本上是通过使用病人的遗传学和其他基本分子信息来进行有效的治疗。例如，在2020年，根据进展报告的范围和意义，专门药物报告约占该年美国食品和药物管理局批准的新药总数的39%。

研究和开发活动的上升

医学和生物化学领域的研发活动数量的上升正在推动市场的增长。由于遗传性疾病、传染病和癌症的增加，治疗的复杂性增加，正在推动全球市场的增长。在各个领域，如基因组学和蛋白质组学，越来越多地采用测序技术，以及测序成本的降低都在支持市场的增长。此外，政府和非政府组织对研究和开发活动的大量投资以及对特定疾病的基因组研究的拨款正在推动市场的增长。例如，制药公司辉瑞公司将其研发支出从2019年的86.5亿美元提高到2020年的94亿美元。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告可提供以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和简介。

目录

第一章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19对全球毛细管电泳市场的影响

第五章：客户的声音

第六章：全球毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按公司分类(2021年)
    • 按地区分类
  • 市场地图

第七章：北美毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值分类
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第八章：欧洲毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲毛细管电泳的市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按组件（仪器、耗材、软件）分类
    • 按模式（毛细管区间电泳、毛细管电色谱、其他）分类
    • 按应用（核酸分析 v/ 蛋白质分析）分类
    • 按终端用户（生物技术和制药公司、临床实验室、学术和研究机构、其他）分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 毛细管电泳
    • 沙特阿拉伯 毛细管电泳
    • 阿联酋 毛细管电泳
    • 土耳其 毛细管电泳
    • 埃及 毛细管电泳

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

第十四章：竞争格局

  • QIAGEN NV Thermo Fischer Scientific, Inc.安捷伦科技公司（Agilent Technologies, Inc.Bio-Rad Laboratories, Inc.Danaher Corporation PerkinElmer, Inc.Merck KGaA Promega Corporation Shimadzu Corporation LABGENE Scientific SA

第十五章：战略建议

简介目录
Product Code: 12992

The global capillary electrophoresis market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing incidences of various types of cancers, genetic disorders, and infectious diseases, growing demand for innovative therapies and drugs, and an increase in investments in R&D are propelling the growth of the market. Capillary electrophoresis is a separation method that separates ions analytically based on their electrophoretic mobility by applying a suitable voltage. It is used predominately because of the faster results and separates with high resolution. This electrophoresis technique is extensively used in biosciences and clinical research. The other factors supporting the market's growth are, rise in R&D activities, increased proteomics, and genomics research, increasing demand for personalized medicine, growing aging population base, increasing healthcare expenditure, increasing application of electrophoresis in the field of drug discovery, growing number of mergers and strategic acquisitions, increasing need for DNA analysis, and technological advancements.

Rising Prevalence of Cancer

The growing number of people suffering from different types of cancer, such as breast cancer, cervical, lung, and others, is augmenting the growth of the market. As per the American Heart Association, cardiovascular diseases cause 17.3 million deaths per year. Owing to the rise in incidences of cancer, the demand for early diagnosis and effective treatment is also rising, which fuels the growth of the market. For instance, in 2018, as per the International Agency for Research on Cancer (IARC), there were 17.0 million new cancer cases and 9.5 million cancer deaths across the world.

Increasing Demand for Personalized Medicine

Nowadays, the demand for precision medicine is rising, which is a key factor in bolstering the growth of the market. This is attributed to its potential to tailor therapy with the best response and to reduce any adverse events. It is basically used to have effective treatment by using a patient's genetics and other essential molecular information. For instance, in 2020, according to the scope and significance of the progress report, specialized medicines reported for about 39 percent of the total FDA-approved new drugs in the year.

Rise in Research and Development Activities

The rise in the number of R&D activities in the medical and biochemistry sector is fueling the growth of the market. Owing to the rise in genetic disorders, infectious diseases, and cancer, an increase in complexities in treatments is surging the growth of the market globally. Increasing adoption of sequencing in various fields, such as genomics and proteomics, and reduction in the cost of sequencing are supporting the growth. Furthermore, heavy investments by government and non-government organizations for research and development activities and grants for specific disease-targeted genomic research are fueling the growth of the market. For instance, pharmaceutical company Pfizer enhanced their R&D expenditure from $8.65 billion in 2019 to $9.4 billion in 2020.

Market Segmentation

The global capillary electrophoresis market is segmented into component, mode application, end user, and company. Based on components, the market is divided into instruments, consumables, and software. Based on mode, the market is divided into capillary zone electrophoresis, capillary electrochromatography, and others. Based on application, the market is divided into nucleic acid analysis and protein analysis. Based on nucleic acid analysis, the market is further segmented into DNA fragment analysis and RNA/mRNA analysis. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, clinical laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising research and development (R&D) activities in the country.

Market Players

QIAGEN NV, Thermo Fischer Scientific, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, PerkinElmer, Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, and LABGENE Scientific SA are some of the leading companies operating in the market.

Report Scope

In this report, global capillary electrophoresis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Capillary Electrophoresis Market, By Component:

  • Instruments
  • Consumables
  • Software

Capillary Electrophoresis Market, By Mode:

  • Capillary Zone Electrophoresis
  • Capillary Electro Chromatography
  • Others

Capillary Electrophoresis Market, By Application:

  • Nucleic Acid Analysis
    • DNA Fragment Analysis
    • RNA/mRNA Analysis
  • Protein Analysis

Capillary Electrophoresis Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Clinical Laboratories
  • Academic & Research Institutions
  • Others

Capillary Electrophoresis Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Capillary Electrophoresis Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Capillary Electrophoresis Market

5. Voice of Customer

6. Global Capillary Electrophoresis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component (Instruments, Consumables, Software)
    • 6.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 6.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 6.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Market Map

7. North America Capillary Electrophoresis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component (Instruments, Consumables, Software)
    • 7.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 7.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 7.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 7.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Capillary Electrophoresis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Canada Capillary Electrophoresis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Mexico Capillary Electrophoresis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Capillary Electrophoresis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component (Instruments, Consumables, Software)
    • 8.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 8.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 8.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 8.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Capillary Electrophoresis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Capillary Electrophoresis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Capillary Electrophoresis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Capillary Electrophoresis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Capillary Electrophoresis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Capillary Electrophoresis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component (Instruments, Consumables, Software)
    • 9.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 9.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 9.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 9.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Capillary Electrophoresis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Capillary Electrophoresis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Capillary Electrophoresis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Capillary Electrophoresis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Component
        • 9.3.4.2.2. By Mode
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Capillary Electrophoresis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Component
        • 9.3.5.2.2. By Mode
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Capillary Electrophoresis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component (Instruments, Consumables, Software)
    • 10.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 10.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 10.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 10.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Capillary Electrophoresis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Capillary Electrophoresis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Capillary Electrophoresis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Capillary Electrophoresis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Component (Instruments, Consumables, Software)
    • 11.2.2. By Mode (Capillary Zone Electrophoresis, Capillary Electro Chromatography, Others)
    • 11.2.3. By Application (Nucleic Acid Analysis v/s Protein Analysis)
      • 11.2.3.1. By Nucleic Acid Analysis (DNA Fragment Analysis v/s RNA/mRNA Analysis)
    • 11.2.4. By End User (Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Academic & Research Institutions, Others)
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Capillary Electrophoresis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Component
        • 11.3.1.2.2. By Mode
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Capillary Electrophoresis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Component
        • 11.3.2.2.2. By Mode
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Capillary Electrophoresis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Component
        • 11.3.3.2.2. By Mode
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User
    • 11.3.4. Turkey Capillary Electrophoresis Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Component
        • 11.3.4.2.2. By Mode
        • 11.3.4.2.3. By Application
        • 11.3.4.2.4. By End User
    • 11.3.5. Egypt Capillary Electrophoresis Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Component
        • 11.3.5.2.2. By Mode
        • 11.3.5.2.3. By Application
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. QIAGEN NV
  • 14.2. Thermo Fischer Scientific, Inc.
  • 14.3. Agilent Technologies, Inc.
  • 14.4. Bio-Rad Laboratories, Inc.
  • 14.5. Danaher Corporation
  • 14.6. PerkinElmer, Inc.
  • 14.7. Merck KGaA
  • 14.8. Promega Corporation
  • 14.9. Shimadzu Corporation
  • 14.10. LABGENE Scientific SA

15. Strategic Recommendations